University of Helsinki
- Country
- 🇫🇮Finland
- Ownership
- Private
- Established
- 1640-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.helsinki.fi
Clinical Trials
128
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (96 trials with phase data)• Click on a phase to view related trials
SAGA for Toddlers. Supporting Children's Linguistic and Socio-Emotional Development in Early Childhood Education and Care
- Conditions
- Social Emotional CompetenceLanguage Development
- First Posted Date
- 2025-09-23
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 120
- Registration Number
- NCT07189104
- Locations
- 🇫🇮
University of Helsinki, Helsinki, Uusimaa, Finland
Physiological, Hormonal, and DNA-based Mechanisms of Psychosocial Stress and Therapeutic Effect
- Conditions
- Well-Being, PsychologicalLoneliness
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-29
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 148
- Registration Number
- NCT07152652
- Locations
- 🇫🇮
University of Helsinki, Helsinki, Uusimaa, Finland
tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment
- Conditions
- Breast Cancer SurvivorObesity, Overweight
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 40
- Registration Number
- NCT07112521
- Locations
- 🇫🇮
Department of Psychology, Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland
NutFinForce: The Impact of Digitally Delivered Lifestyle Performance Medicine Intervention on Defense Performance in Finland
- Conditions
- No Condition
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 5000
- Registration Number
- NCT06799988
- Locations
- 🇫🇮
University of Helsinki, Helsinki, Finland
Accuracy of EEG Slow Wave Activity in Predicting Favourable Outcome in Patients With Hypoxic Brain Injury - A Substudy of STEPCARE Trial
- Conditions
- Out-Of-Hospital Cardiac Arrest
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 300
- Registration Number
- NCT06564675
- Locations
- 🇫🇮
Helsinki University Hospital, Helsinki, Finland
🇫🇮Kuopio University Hospital, Kuopio, Finland
🇫🇮Tampere University Hospital, Tampere, Finland
- Prev
- 1
- 2
- 3
- 4
- 5
- 26
- Next
News
Drug Sensitivity Testing Personalizes AML Treatment and Improves Outcomes
A Finnish study demonstrates that drug sensitivity testing can identify acute myeloid leukemia (AML) patients likely to benefit from venetoclax and azacitidine, improving treatment outcomes.